These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 8625298)
21. Monoterpenes enhanced the sensitivity of head and neck cancer cells to radiation treatment in vitro. Samaila D; Toy BJ; Wang RC; Elegbede JA Anticancer Res; 2004; 24(5A):3089-95. PubMed ID: 15517920 [TBL] [Abstract][Full Text] [Related]
22. Recombinant human interferon alpha-2b enhances the radiosensitivity of small cell lung cancer in vitro. Kardamakis D; Gillies NE; Souhami RL; Bewerley PC Anticancer Res; 1989; 9(4):1041-4. PubMed ID: 2554785 [TBL] [Abstract][Full Text] [Related]
23. The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck. Eke I; Leonhardt F; Storch K; Hehlgans S; Cordes N PLoS One; 2009 Jul; 4(7):e6434. PubMed ID: 19649326 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Moore DM; Kalvakolanu DV; Lippman SM; Kavanagh JJ; Hong WK; Borden EC; Paredes-Espinoza M; Krakoff IH Semin Hematol; 1994 Oct; 31(4 Suppl 5):31-7. PubMed ID: 7831583 [TBL] [Abstract][Full Text] [Related]
25. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy. Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916 [No Abstract] [Full Text] [Related]
26. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236 [TBL] [Abstract][Full Text] [Related]
27. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715 [TBL] [Abstract][Full Text] [Related]
28. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Huang SM; Li J; Armstrong EA; Harari PM Cancer Res; 2002 Aug; 62(15):4300-6. PubMed ID: 12154033 [TBL] [Abstract][Full Text] [Related]
29. Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo. Gabryś D; Dörfler A; Yaromina A; Hessel F; Krause M; Oertel R; Baumann M Strahlenther Onkol; 2008 Jan; 184(1):48-53. PubMed ID: 18188523 [TBL] [Abstract][Full Text] [Related]
31. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546 [TBL] [Abstract][Full Text] [Related]
32. 13-cis-retinoic acid plus interferon-alpha: a phase II clinical study in squamous cell carcinoma of the lung and the head and neck. Roth AD; Abele R; Alberto P Oncology; 1994; 51(1):84-6. PubMed ID: 8265109 [TBL] [Abstract][Full Text] [Related]
33. 13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitro. Benthin M; Dallmann I; Atzpodien J Cancer Biother Radiopharm; 2001 Aug; 16(4):323-31. PubMed ID: 11603003 [TBL] [Abstract][Full Text] [Related]
34. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Eisenhauer EA; Lippman SM; Kavanagh JJ; Parades-Espinoza M; Arnold A; Hong WK; Massimini G; Schleuniger U; Bollag W; Holdener EE Leukemia; 1994; 8 Suppl 3():S38-41. PubMed ID: 7808023 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha]. Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740 [TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck. Jääskelä-Saari HA; Kairemo KJ; Jekunen AP; Pekkola-Heino K; Kulmala J; Ramsay HA; Grenman R Cancer Detect Prev; 1996; 20(4):279-84. PubMed ID: 8818387 [TBL] [Abstract][Full Text] [Related]
37. Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line. Kim HK; Zwelling LA; Sacks PG; Hong WK; Chan D; Silberman L; Glisson BS Cancer Res; 1989 Mar; 49(5):1197-201. PubMed ID: 2537145 [TBL] [Abstract][Full Text] [Related]
38. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651 [TBL] [Abstract][Full Text] [Related]
39. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix. Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672 [TBL] [Abstract][Full Text] [Related]
40. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts. Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]